Check if trademark OPHTHOCANN is available

USPTO Filing History

Key events recorded for this trademark application

2014-12-01 — Application filed
2014-12-04 — Application filed
2014-12-09 — Application filed
2015-03-03 — Assigned to examiner
2015-03-05 — Teas change of correspondence received
2015-03-09 — Approved for pub - principal register
2015-03-19 — Teas change of correspondence received
2015-03-28 — Assigned to lie
2015-03-28 — Law office publication review completed
2015-04-15 — Notification of notice of publication e-mailed
2015-05-05 — Published for opposition
2015-05-05 — Official gazette publication confirmation e-mailed
2015-06-30 — Noa e-mailed - sou required from applicant
2015-08-07 — Teas revoke/app/change addr of atty/dom rep received
2015-08-07 — Attorney/dom.rep.revoked and/or appointed
2015-12-29 — Teas change of correspondence received
2015-12-29 — Sou teas extension received
2015-12-29 — Sou extension 1 filed
2015-12-29 — Sou extension 1 granted
2015-12-31 — Notice of approval of extension request e-mailed
2016-06-07 — Teas revoke/app/change addr of atty/dom rep received
2016-06-07 — Attorney/dom.rep.revoked and/or appointed
2016-06-16 — Sou teas extension received
2016-06-16 — Sou extension 2 filed
2016-07-23 — Case assigned to intent to use paralegal
2016-08-02 — Sou extension 2 granted
2016-08-03 — Notice of approval of extension request e-mailed
2016-12-24 — Sou teas extension received
2016-12-24 — Sou extension 3 filed
2016-12-24 — Sou extension 3 granted
2016-12-27 — Notice of approval of extension request e-mailed
2017-06-29 — Sou teas extension received
2017-06-29 — Sou extension 4 filed
2017-06-29 — Sou extension 4 granted
2017-07-01 — Notice of approval of extension request e-mailed
2017-12-20 — Sou teas extension received
2017-12-20 — Sou extension 5 filed
2017-12-26 — Sou extension 5 granted
2017-12-27 — Notice of approval of extension request e-mailed
2018-01-08 — Teas change of correspondence received
2018-03-08 — Teas change of correspondence received
2018-05-31 — Assigned to examiner
2018-06-25 — Teas statement of use received
2018-06-25 — Use amendment filed
2018-06-27 — Statement of use processing complete
2018-06-28 — Allowed principal register - sou accepted
2018-06-29 — Notice of acceptance of statement of use e-mailed
2018-07-20 — Teas change of correspondence received
2018-07-31 — Registered-principal register
2020-05-15 — Attorney/dom.rep.revoked and/or appointed
2020-05-15 — Teas change of owner address received
2020-05-15 — Teas revoke/app/change addr of atty/dom rep received
2020-05-15 — Teas change of correspondence received
2020-05-15 — Applicant/correspondence changes (non-responsive) entered
2020-06-03 — Automatic update of assignment of ownership
2020-06-18 — Teas change of correspondence received
2020-06-18 — Teas change of owner address received
2020-06-18 — Teas revoke/app/change addr of atty/dom rep received
2020-06-18 — Attorney/dom.rep.revoked and/or appointed
2020-06-18 — Applicant/correspondence changes (non-responsive) entered
2020-09-17 — Teas revoke/app/change addr of atty/dom rep received
2020-09-17 — Attorney/dom.rep.revoked and/or appointed
2020-09-17 — Teas change of correspondence received
2023-07-31 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2023-09-14 — Teas revoke/app/change addr of atty/dom rep received
2023-09-14 — Attorney/dom.rep.revoked and/or appointed
2023-09-14 — Teas change of correspondence received
2024-02-27 — Applicant/correspondence changes (non-responsive) entered
2024-02-27 — Teas revoke/app/change addr of atty/dom rep received
2024-02-27 — Teas change of correspondence received
2024-02-27 — Teas change of owner address received
2024-02-27 — Attorney/dom.rep.revoked and/or appointed
2025-02-14 — Cancelled sec. 8 (6-yr)
2025-02-14 — Final status recorded

Owner Information

APIRX PHARMACEUTICAL USA, LLC
NEW YORK , NY

AXIM Biotechnologies, Inc.
New York , NY

AXIM Biotechnologies, Inc.
5th Floor , NY

Correspondent

Ian W. Gillies Knobbe Martens Olson & Bear, LLP
2040 Main Street, 14th floor
Irvine, CA 92614
United States

Filing Details

Filing Date:
2014-12-01

Status Date:
2025-02-14

Category:
Pharmaceuticals

Filing Year:
2014